Return to search

Exploring the impact of the tumor microenvironment on nuclear morphometry: lessons learned for sensitivity to cytotoxic treatment

<p>Breast cancer remains the leading cause of death among
females worldwide. While systemic therapy for breast cancer may work
effectively in the early phases, for more than 10% of primary and 50% of
metastatic cases, the disease eventually progresses, resisting treatments. To
overcome this issue, recognizing markers of resistance as early as possible is
critical. However, the underlying mechanisms of resistance remains elusive. The
influence of microenvironmental factors of the extracellular matrix (ECM) on
tumor behavior has been revealed relatively recently and increased stiffness of
ECM is associated with cancer progression. Additionally, impacts of other
matrix components such as non-neoplastic epithelial cells (that may constitute
an important portion of the tumor microenvironment -TME) are suspected to
influence tumors but they have not been investigated in detail. Besides, it is
not known whether the response to increasing stiffness depends on the subtypes
of breast cancer. Here, using breast models in 3D cell culture we have shown
that the non-neoplastic epithelial compartment can influence the effect of
matrix stiffness even for tumors recognized as highly aggressive. The degree of
tumor aggressiveness recognizable via tumor architecture is associated with a
differential behavior when ECM stiffness changes. In a 3D microenvironmental context, which provides an
optimal level of constraints for tumors to display their phenotype, we report
stiffness and paracrine influence impact on cisplatin-mediated cytotoxicity,
which correlates with distinct nuclear morphometry and distribution pattern
associated with population heterogeneity. The response pattern varies across cell
lines representing higher and lower levels of aggressiveness in the basal-like
subtypes of breast cancer. Our results also highlight the need for integrating biochemical
and physical components of the TME in future designs of <i>in vitro</i> drug
screening platforms.</p>

  1. 10.25394/pgs.14522394.v1
Identiferoai:union.ndltd.org:purdue.edu/oai:figshare.com:article/14522394
Date05 May 2021
CreatorsApekshya Chhetri (10731045)
Source SetsPurdue University
Detected LanguageEnglish
TypeText, Thesis
RightsCC BY 4.0
Relationhttps://figshare.com/articles/thesis/Exploring_the_impact_of_the_tumor_microenvironment_on_nuclear_morphometry_lessons_learned_for_sensitivity_to_cytotoxic_treatment/14522394

Page generated in 0.002 seconds